Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene

Ornithine transcarbamylase (OTC) deficiency is the most common inherited disorder of the urea cycle and is transmitted as an X‐linked trait. Defects in the OTC gene cause a block in ureagenesis resulting in hyperammonemia, which can lead to brain damage and death. Three previous mutation updates for the OTC gene have been published, in 1993, 1995, and 2002. The most recent comprehensive update, in 2002, contained 244 mutations including 13 nondisease‐causing mutations and polymorphisms. This current update reports 341 mutations, of which 93 have not been previously reported, and an additional 29 nondisease‐causing mutations and polymorphisms. Out of the 341 mutations, 149 were associated with neonatal onset of hyperammonemia (within the first week of life), 70 were seen in male patients with later onset of hyperammonemia, and 121 were found in heterozygous females (one unknown). Along with the reported mutations, residual enzyme activities and other pertinent clinical information are included whenever available. Most mutations in the OTC gene are specific to a particular family (“private” mutations). They are distributed throughout the gene, with a significant paucity of mutations in the 32 first codons encoding the “leader” peptide (exon 1 and the beginning of exon 2). Almost all mutations in consensus splice sites confer a neonatal onset phenotype. Using the current molecular screening methods, mutations are found in about 80% of the patients. The remaining patients may have mutations in regulatory domains or mutations deep in the introns, which constitute 98.5% of the genomic sequence. In addition, a phenocopy of OTC deficiency caused by mutations in another unknown gene cannot be excluded. Hum Mutat 27(7):626–632, 2006. Published 2006 Wiley‐Liss, Inc.

[1]  A. Munnich,et al.  Fatal hyperammonemia resulting from a C-to-T mutation at a MspI site of the ornithine transcarbamylase gene , 1991, Human Genetics.

[2]  R. Nussbaum,et al.  An arginine to glutamine mutation in residue 109 of human ornithine transcarbamylase completely abolishes enzymatic activity in Cos1 cells. , 1989, The Journal of clinical investigation.

[3]  S. Malcolm,et al.  Novel mutation affecting a splice site in exon 4 of the ornithine carbamoyl transferase gene. , 1993, Human molecular genetics.

[4]  S. Brusilow,et al.  Late-onset ornithine transcarbamylase deficiency in male patients. , 1990, The Journal of pediatrics.

[5]  M. Tuchman,et al.  Screening for gene deletions and known mutations in 13 patients with ornithine transcarbamylase deficiency. , 1992, Biochemical medicine and metabolic biology.

[6]  M. Tuchman,et al.  Carbamyl Phosphate Synthetase and Ornithine Transcarbamylase Activities in Enzyme-Deficient Human Liver Measured by Radiochromatography and Correlated with Outcome , 1989, Pediatric Research.

[7]  Chung-I Wu,et al.  Inequality in mutation rates of the two strands of DNA , 1987, Nature.

[8]  Y. Kuroda,et al.  Ornithine transcarbamylase deficiency resulting from a C-to-T substitution in exon 5 of the ornithine transcarbamylase gene. , 1989, American journal of human genetics.

[9]  S. Powers-Lee,et al.  The interaction of rat liver carbamoyl phosphate synthetase and ornithine transcarbamoylase with inner mitochondrial membranes. , 1987, The Journal of biological chemistry.

[10]  D. Barker,et al.  Restriction sites containing CpG show a higher frequency of polymorphism in human DNA , 1984, Cell.

[11]  S. Brusilow,et al.  Differentiation of transient hyperammonemia of the newborn and urea cycle enzyme defects by clinical presentation. , 1985, The Journal of pediatrics.

[12]  U. Francke,et al.  Human ornithine transcarbamylase locus mapped to band Xp21.1 near the Duchenne muscular dystrophy locus. , 1984, Science.

[13]  T. Tsuzuki,et al.  Structure of the human ornithine transcarbamylase gene. , 1988, Journal of biochemistry.

[14]  N. Glansdorff,et al.  Nucleotide sequence of the ARG3 gene of the yeast Saccharomyces cerevisiae encoding ornithine carbamoyltransferase. Comparison with other carbamoyltransferases. , 1987, European journal of biochemistry.

[15]  C. Caskey,et al.  Improved molecular diagnostics for ornithine transcarbamylase deficiency. , 1991, American journal of human genetics.

[16]  R. Nussbaum,et al.  Mosaicism for an intragenic deletion in a boy with mild ornithine transcarbamylase deficiency. , 1988, The New England journal of medicine.

[17]  P. Marynen,et al.  Sporadic late onset ornithine transcarbamylase deficiency in a boy with somatic mosaicism for an intragenic deletion , 1990, Clinical genetics.

[18]  K. Davies,et al.  PRENATAL EXCLUSION OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY BY DIRECT GENE ANALYSIS , 1985, The Lancet.

[19]  K. Furtak,et al.  Mitochondrial import and processing of mutant human ornithine transcarbamylase precursors in cultured cells , 1988, Molecular and cellular biology.

[20]  M. Tuchman,et al.  Six New Mutations in the Ornithine Transcarbamylase Gene Detected by Single-Strand Conformational Polymorphism , 1992, Pediatric Research.

[21]  K. Shimada,et al.  For novel gene mutations in five Japanese male patients with neonatal or late onset OTC deficiency: application of PCR-single-strand conformation polymorphisms for all exons and adjacent introns , 1993, Human Genetics.

[22]  I. Matsuda,et al.  Estimated frequency of urea cycle enzymopathies in Japan. , 1991, American journal of medical genetics.

[23]  R. Doolittle,et al.  Structure and expression of a complementary DNA for the nuclear coded precursor of human mitochondrial ornithine transcarbamylase. , 1984, Science.

[24]  A. Munnich,et al.  Site specific screening for point mutations in ornithine transcarbamylase deficiency. , 1992, Journal of medical genetics.

[25]  D. Muzny,et al.  Scanning detection of mutations in human ornithine transcarbamoylase by chemical mismatch cleavage. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Williams,et al.  A cDNA clone for the precursor of rat mitochondrial ornithine transcarbamylase: comparison of rat and human leader sequences and conservation of catalytic sites. , 1985, Nucleic acids research.

[27]  W. Fenton,et al.  Identification of RNA splicing errors resulting in human ornithine transcarbamylase deficiency. , 1991, American journal of human genetics.

[28]  M. Tuchman.  The clinical, biochemical, and molecular spectrum of ornithine transcarbamylase deficiency. , 1992, The Journal of laboratory and clinical medicine.

[29]  S. Brusilow,et al.  Natural history of symptomatic partial ornithine transcarbamylase deficiency. , 1986, The New England journal of medicine.

[30]  W. Lipscomb,et al.  2.5 A structure of aspartate carbamoyltransferase complexed with the bisubstrate analog N-(phosphonacetyl)-L-aspartate. , 1987, Journal of molecular biology.

[31]  M. Tuchman,et al.  Heterogeneity of patients with late onset ornithine transcarbamylase deficiency. , 1991, Clinical and investigative medicine. Medecine clinique et experimentale.

[32]  S. Brusilow,et al.  Use of denaturing gradient gel electrophoresis for detection of mutation and prospective diagnosis in late onset ornithine transcarbamylase deficiency. , 1990, Genomics.

[33]  M. Tuchman,et al.  Single-strand conformational polymorphism and direct sequencing applied to carrier testing in families with ornithine transcarbamylase deficiency , 1993, Human Genetics.

[34]  R. Rozen,et al.  Gene deletion and restriction fragment length polymorphisms at the human ornithine transcarbamylase locus , 1985, Nature.

[35]  M. Tuchman,et al.  Four new mutations in the ornithine transcarbamylase gene. , 1993, Biochemical medicine and metabolic biology.

[36]  M. Tuchman,et al.  Seven new mutations in the human ornithine transcarbamylase gene , 1994, Human mutation.

[37]  Y. Sakaki,et al.  Four newly identified ornithine transcarbamylase (OTC) mutations (D126G, R129H, I172M and W332X) in Japanese male patients with early‐onset OTC deficiency , 1994, Human mutation.

[38]  R. Nussbaum,et al.  Characterization of point mutations in the same arginine codon in three unrelated patients with ornithine transcarbamylase deficiency. , 1988, The Journal of clinical investigation.

[39]  A. Horwich,et al.  Targeting of pre-ornithine transcarbamylase to mitochondria: Definition of critical regions and residues in the leader peptide , 1986, Cell.